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The medial prefrontal cortex (mPFC) is involved in a wide range of executive cognitive
functions, including reward evaluation, decision-making, memory extinction, mood, and
task switching. Manipulation of the mPFC has been shown to alter food intake and
food reward valuation, but whether exclusive stimulation of mPFC pyramidal neurons
(PN), which form the principle output of the mPFC, is sufficient to mediate food
rewarded instrumental behavior is unknown. We sought to determine the behavioral
consequences of manipulating mPFC output by exciting PN in mouse mPFC during
performance of a panel of behavioral assays, focusing on food reward. We found
that increasing mPFC pyramidal cell output using designer receptors exclusively
activated by designer drugs (DREADD) enhanced performance in instrumental food
reward assays that assess food seeking behavior, while sparing effects on affect and
food intake. Specifically, activation of mPFC PN enhanced operant responding for
food reward, reinstatement of palatable food seeking, and suppression of impulsive
responding for food reward. Conversely, activation of mPFC PN had no effect
on unconditioned food intake, social interaction, or behavior in an open field.
Furthermore, we found that behavioral outcome is influenced by the degree of
mPFC activation, with a low drive sufficient to enhance operant responding and a
higher drive required to alter impulsivity. Additionally, we provide data demonstrating
that DREADD stimulation involves a nitric oxide (NO) synthase dependent pathway,
similar to endogenous muscarinic M3 receptor stimulation, a finding that provides
novel mechanistic insight into an increasingly widespread method of remote neuronal
control.
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INTRODUCTION
The medial prefrontal cortex (rodent prelimbic and infralimbic
cortex, mPFC) is implicated in the control of a host of executive
cognitive functions including reward valuation (Grabenhorst
and Rolls, 2011), decision-making (Euston et al., 2012),
memory extinction (Maroun, 2013), attention (Clark and
Noudoost, 2014), task switching (Kehagia et al., 2010), and the
regulation of affect (Price and Drevets, 2012). Accordingly,
alteration in prefrontal function has been noted in disorders
associated with dysregulated executive control including
addiction, post-traumatic stress disorder, mood disorders, and
compulsive disorders. Likewise, manipulation of mPFC neurons
pharmacologically, optogenetically, electrophysiologically, and
by lesioning in model organisms has demonstrated involvement
of this brain area in many aspects of executive function
(Kesner and Churchwell, 2011; Cassaday et al., 2014; Riga et al.,
2014).
In addition, the mPFC is involved in modulating food
intake and food reward. Pharmacological and optogenetic
manipulation of the mPFC can drive unconditioned feeding
in sated animals (Mena et al., 2011, 2013; Land et al., 2014).
Cued feeding has also been shown to require mPFC activity
(Petrovich et al., 2007). Operant responding for palatable
food is also regulated by the mPFC; stimulating µ-opioid
receptors (MORs) in the ventral mPFC increases the breakpoint
on a progressive ratio (PR) operant schedule (Mena et al.,
2013), while antagonizing opioid signaling in the mPFC
via naltrexone infusion decreases operant responding for a
food reward (Blasio et al., 2014). Likewise, infusion of the
dopamine type-1 receptor antagonist SCH-23390 attenuates
the expression of instrumental learning (Baldwin et al., 2002).
Furthermore, the activity of mPFC neurons tracks with
reward receipt in rats, as the animal engages the mPFC in
calculating the costs associated with reward seeking (Burgos-
Robles et al., 2013; Horst and Laubach, 2013). Reinstatement
of palatable food seeking, a model of dietary relapse, is
associated with increased c-Fos induction in the mPFC (Cifani
et al., 2012), and optogenetic manipulation of mPFC function
interferes with reinstatement in a stimuli-specific manner
(Calu et al., 2013). These data and others strongly implicate
the mPFC, and especially metabotropic receptor signaling
within the mPFC, in regulating food intake and reward.
However, a mechanistic understanding of these results on a
cellular/circuit level is complicated by the fact that within
the mPFC both glutamatergic pyramidal projection neurons
and GABAergic local interneurons express dopamine and
opioid receptors, as well as other metabotropic receptors likely
involved in modulating food intake and reward, prohibiting
assignment of function to a particular cell type (Steketee,
2003).
We hypothesized that selectively depolarizing mPFC
pyramidal neurons (PN) in the mouse would be sufficient
to modulate performance in both feeding assays and in
assays that measure how the mPFC regulates food seeking
behavior. Using an adeno-associated virus (AAV) construct
encoding a Gq-coupled Designer Receptor Exclusively
Activated by Designer Drugs (hM3D(Gq)-DREADD;
Armbruster et al., 2007; Alexander et al., 2009; Krashes
et al., 2011) under control of the calcium-calmodulin
dependent protein kinase II alpha (CamKIIα) promoter,
we investigated whether increasing the excitability of
mPFC PN via metabotropic signaling could selectively alter
behavior.
Our results demonstrate that DREADD-driven neuronal
stimulation is sufficient to enhance both the effort devoted
to food seeking and the reinstatement of cued food seeking
behavior, while reducing motor impulsivity. Intriguingly, our
stimulation paradigm spared effects on unconditioned food
intake, as well as behaviors associated with anxiety, depression,
and social interaction, which have been linked tomPFC function.
Thus, these results suggest that Gq driven neuronal stimulation
of CamKII PN affects food seeking behavior but not the ingestion
of food.
MATERIALS AND METHODS
Animals
For all behavioral experiments, 9 week old male C57BL/6J
mice were purchased from Jackson Laboratory (Bar Harbor,
ME, USA). For studies assessing colocalization of DREADD
or eYFP with dopamine receptor 1 (Drd1), we used mice
expressing Cre recombinase under control of the Drd1 promoter,
which have been described previously (Heusner et al., 2008).
To test the AAV-DIO-Sun2myc vector (below), we used Vgat-
ires-Cre mice from Jackson Laboratory (Stock No. 016962)
crossed with lox-tdTomato mice (Jackson Laboratory, Stock
No. 007914). Mice were housed in the Jordan Hall vivarium
at the University of Virginia on a 12:12 light:dark schedule
with lights-on at 09:00 with free access to food and water,
unless otherwise noted. All testing was performed during the
light portion of the light:dark cycle. All experiments were
performed in accordance with Association for Assessment
of Laboratory Animal Care policies and approved by the
University of Virginia Animal Care and Use Committee.
Four separate cohorts of mice were used for behavioral
and electrophysiological experiments. Cohort 1 participated in
the following experiments, in the following order: Operant
Conditioning, Binge-Like Assay (0.5 mg/kg CNO), Open Field
(0.5 mg/kg CNO), Social Interaction (0.5 mg/kg CNO). Cohort 2
participated in the following experiments, in the following
order: Reinstatement, Binge-Like Assay (2.5 mg/kg CNO),
Fast-Refeed, Open Field (2.5 mg/kg CNO), Social Interaction
(2.5 mg/kg CNO). Cohort 3 only participated in the Impulsivity
Assay. Cohort 4 only participated in electrophysiological
studies.
Adeno-Associated Virus Vectors and
Stereotaxic Viral Injection
For expression of hM3D(Gq) in mPFC PN for behavioral
assessment, we used the AAV-CaMKIIa-HA-hM3D(Gq)-
IRES-mCitrine vector (UNC Vector Core). For colocalization
studies, we used the AAV-CaMKIIa-hM3D(Gq)-mCherry
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and AAV-CaMKIIa-EYFP vectors (UNC Vector Core).
Likewise, for electrophysiological experiments we used the
AAV-CaMKIIa-hM3D(Gq)-mCherry vector, as the mCherry
fluorophore is more readily detectable by epifluorescence.
Our Cre recombinase dependent vector AAV-DIO-SUN2-
myc was also produced by the UNC Vector Core. Virus was
delivered via stereotaxic injection. Mice were anesthetized
with ketamine/dexmeditomidine solution and mounted on a
stereotaxic apparatus. Anesthesia was maintained by inhaled
isoflurane for the duration of the procedure. A small hole
was opened in the skull, and a pulled glass micropipette was
lowered to the target site (from Bregma, +2.05 mm anterior,
±0.35 mm lateral, and −1.50 mm ventral of dura). 200 nl of
virus was injected with pressure at a rate of ∼50 nl/min. After
injection the micropipette was maintained in place for 4 min
before retraction. This procedure was repeated bilaterally. The
incision was then cleaned and closed with a surgical staple.
Mice were given atimpamezole and ketoprofen immediately
following surgery, and ketoprofen was administered for 3
days post-surgery. Mice were allowed to recover for at least 3
weeks following surgery before commencement of behavioral
testing.
Generation of AAV-DIO-Sun2myc
We developed a novel cre dependent viral marker for assessing
the expression of the Drd1 receptor in the mPFC. A mouse
Sun2 (Genbank AY682987)-C-terminal myc tagged fusion
cDNA was synthesized by Genscript (Piscataway, NJ, USA),
containing both 5′ NheI and 3′ AscI restriction sites. This
DNA fragment was then cloned into the unique NheI-AscI
restriction sites of pAAV-EF1a-double floxed-hChR2(H134R)-
EYFP-WPRE-HGHpA (gift from Karl Deisseroth—Addgene
plasmid #20298). The subsequent construct then contained
the Sun2-myc fusion (removing hChR2(H134R)-EYFP) in
inverse orientation from the EF1a promoter. Cre recombinase
expression then reverses the orientation of the Sun2-myc
cassette and allows expression. AAV viral particles were then
prepared by the University of North Carolina’s Vector Core
Facility.
Single-cell RT-PCR
Individual mCherry-labeled neurons were harvested frommouse
prelimbic cortex acutely, essentially as described previously
(Wang et al., 2013; Kumar et al., 2015). Briefly, single
fluorescent cells were identified in the recording chamber of a
fluorescence microscope (Zeiss Axioimager FS) and aspirated
into a glass capillary. The tip was broken and contents
expelled into a sterile Eppendorf tube containing dNTPs,
BSA, RNaseOUT, oligo-dT and random hexamers; this pre-
RT mixture was incubated at 65◦C for 5 min then cooled to
4◦C for 1 min. First strand cDNA synthesis was performed
with Superscript III Reverse Transcriptase, RNA was digested
with RNase H and cDNA and stored at −20◦C. Analysis
of multiple genes in single cell assays employed multiplex
nested single cell RT-PCR (sc-PCR). All primer sets were
independently validated and no-template negative controls
were included for each reaction. Primers for VGLUT1 and
GAD65a were previously reported (Cabezas et al., 2013), as
were primers for GAD65b, parvalbumin (PARV), somatostatin
(SOM), and VIP (Sosulina et al., 2010), and for GAPDH,
VGLUT2, and GAD67 (Wang et al., 2013; Kumar et al.,
2015).
Electrophysiology
Coronal brain slices (300 µm) containing the mPFC were
prepared from AAV hM3Dq-DREADD-injected mice.
Animals were euthanized with isoflurane, decapitated, and
their brains were rapidly removed and submerged in ice cold
artificial cerebral spinal fluid (ACSF) containing (in mM):
125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, 0.5
L-ascorbic acid, 2 pyruvate, 10 glucose, and 25 NaHCO3
(oxygenated with 95% O2 and 5% CO2). Slices were prepared
using a Vibratome (Vibratome 1000 Plus), transferred to a
chamber containing oxygenated ACSF, incubated at 37◦C
for 35 min, and then stored at room temperature. For
recordings, slices were held in a small chamber superfused
with heated (32◦C) oxygenated ACSF at 3 mL/min. For
electrophysiology experiments, mPFC neurons were visually
identified using fluorescent microscopy using a Zeiss Axioscope
microscope (Zeiss, Oberkochen, Germany). Whole-cell current
clamp recordings were performed using an Axopatch 700B
amplifier (Molecular Devices) using pCLAMP 10 software
(Molecular Devices) and a Digidata 1322A (Molecular Devices).
Electrodes were fabricated from borosilicate glass using a Brown-
Flaming puller (model P97, Sutter Instruments Co). Electrodes
(3.0–3.5 M) were filled with (in mM): 120 Kgluconate,
10 NaCl, 2 MgCl2, 0.5 K2EGTA, 10 HEPES, 4 Na2ATP, 0.3
NaGTP (pH adjusted to 7.2 with KOH). APs were evoked
using a current injection step to 300 and action potential
parameters measured as previously described (Hargus et al.,
2013).
Clozapine-N-Oxide (CNO)
CNO was purchased from Sigma (Cat. No. C0832–5MG) and
dissolved in saline at a concentration of 1 mg/ml, then diluted
to either 0.1 mg/ml (for 0.5 mg/kg injections) or 0.5 mg/ml (for
2.5 mg/kg injections).
Free Feeding Assays
All behavioral testing for the binge-like and fast-refeed assays
occurred in the home cage, in the home room.
Binge-like Feeding Assay
The Binge-like Assay was performed as previously described
(Gaykema et al., 2014). On the night before testing, mice (N = 10)
received a small (<0.1 g) sample of either a highly palatable
high fat, high sugar diet (HFD; Research Diets Inc., D12331,
5.56 kcal/g) in a petri dish to familiarize them with this novel
food. At lights-on all food was removed, and mice received
an injection i.p. of either saline or CNO, equal volume. After
30 min mice were challenged with ∼1.5 g of pre-weighed HFD
in a petri dish, and allowed to consume. After 15 min, 30 min,
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and 1 h the food was removed and weighed, then replaced in
the cage. After 1 h mice were returned to ad lib chow feeding.
The experiment was repeated for 2 days total, such that each
mouse received HFD + saline and HFD + CNO. Mice were
assigned randomly to begin the experiment on either saline or
CNO.
Fast-Refeed Assay
On the day before testing, food was removed at 15:30 (5.5 h
before lights off). At lights-on on the following day, mice
(N = 10) received an injection i.p. of either saline or CNO.
After 30 min mice received ∼3 g of pre-weighed chow in
a petri dish, and were allowed to consume. After 15 min,
30 min, and 1 h the food was removed and weighed, and
mice were returned to ad lib chow feeding. The experiment
was repeated for 2 days total, such that each mouse received
chow + saline and chow + CNO. At least 2 days of ad
lib feeding separated each testing day. Mice were assigned
randomly to begin the experiment on either saline or CNO. The
Fast-Refeed Assay was performed 3 days after the Binge-Like
Assay.
Operant Conditioning
Behavioral testing for the operant conditioning assay occurred
in a dedicated behavior room, separate from the home room.
Testing was performed in sound attenuated boxes (Med-
Associates, St. Alban, VT, USA). Each box was equipped with
three nosepoke holes arranged in a line on one side of the
chamber, and a food magazine on the opposite side. Each
nosepoke hole, as well as the magazine, was equipped with an
infrared beam break detector. Three days prior to training, mice
were placed on food restriction, with access to regular chow
for 3 h/day. Mice were trained for 1 h/day, every day. Prior
to any training, mice initially underwent extinction training
in order to extinguish any innate preferences for any of the
nosepoke holes. In this phase, a nosepoke did not result in any
reward delivery. After passing extinction (fewer than 10 pokes
in any hole in a given session), mice were passed on to fixed
ratio (FR) training. FR training proceeded in three stages, FR1,
FR3, and FR5. In FR1, a single nosepoke in the center hole
resulted in delivery of a food reward (Bio-Serv, Cat. No. F05301)
to the magazine. In FR3, three nosepokes are required for
a reward, and in FR5 five nosepokes are required. A mouse
was considered to have passed a stage when it attained 30
rewards in a single session. Mice were moved from FR1 to
FR3 after passing FR1 one time, moved from FR3 to FR5
after passing FR3 twice, and moved from FR5 to PR testing
after passing FR5 three times. In PR testing, the number of
nosepokes required for a reward increased progressively during
a session, on the following schedule: 5 pokes for the first
reward, then 10, 20, 30, 50, 70, 100, 130, 170, 210, 260, 310,
and finally 370. PR testing lasted for a maximum of 2 h, and
could terminate early if the mouse did not complete any given
stage in 30 min or less. Mice underwent 2 days of PR testing
on food restriction alternating CNO/saline treatment, with half
receiving CNO on the first day and half receiving saline, followed
by 2 days of PR testing after return to ad lib feeding, also
alternating CNO and saline. The chambers were cleaned between
each mouse with Minncare disinfectant to remove residual
odors.
Reinstatement
The Reinstatement Assay is based on a previously reported
assay (Martín-García et al., 2011), with some alterations. The
primary difference is that our mice were maintained on ad
lib feeding throughout the assay, rather than beginning the
initial training period on food restriction. The reinstatement
experiment consisted of three stages: Acquisition, Extinction,
and Reinstatement. During Acquisition, the following program
was used: a nosepoke in the center hole resulted in delivery of
a reward pellet and simultaneous illumination of the nosepoke
hole. Illumination was maintained for 2 s. Pokes into the
left and right holes were recorded, but did not result in any
action. After reward delivery, the mouse was required to enter
the food reward hopper before the program would continue.
After hopper entry, a 10 s hold period followed, in which
nosepokes were counted but did not result in any action.
After the 10 s hold, the cycle began anew, and nosepokes
could again elicit reward delivery and illumination. Acquisition
was considered successful when pokes in the active, center
hole were 70% or greater than total nosepokes (including
pokes in the left and right holes), and total rewards obtained
in a session remained within 20% of the 3 day running
average. After Acquisition, mice passed to Extinction, in which
nosepokes were counted, but did not result in reward delivery
or nosepoke illumination. Extinction continued until total
pokes in the center hole were less than 30% of total pokes
on the center hole during completion of Acquisition for 3
consecutive days. After Extinction, mice underwent a single
day of Reinstatement testing. Thirty minutes prior to testing,
mice received either CNO or saline i.p. Mice were assigned to
the CNO or saline group prior to testing in order to achieve
a comparable distribution of responding during Acquisition
in both groups. During Reinstatement, the center nosepoke
hole was continuously illuminated and mice were allowed to
freely respond for 1 h. No reward was delivered. Poking in
all holes was recorded. The chambers were cleaned between
each mouse with Minncare disinfectant to remove residual
odors.
3-Choice Serial Reaction Time Task
(Impulsivity Assay)
The Impulsivity assay was performed as previously described,
with modifications as noted (Ohmura et al., 2009). Briefly,
training is split into 13 stages. In stage 1, all nosepoke holes
are illuminated, and a nosepoke in any hole results in reward
delivery. In stage 2, only the center nosepoke hole is illuminated,
and only pokes in this hole results in reward delivery. As
training progresses, the duration of nosepoke illumination is
progressively reduced, until in stage 13 it is illuminated for 0.5 s.
Mice must refrain from poking until the hole is illuminated.
After stage 2, the mouse must wait (the intertrial interval (ITI)
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 March 2016 | Volume 10 | Article 63
Warthen et al. mPFC Control of Feeding Behaviors
being 5 s) to identify the correctly lit nosepoke hole prior to
poking, as one of the 3 holes is then illuminated in pseudo
random order. A premature poke results in a 5 s timeout
and no reward. Likewise, mice must poke within 2 s of light
illumination. No response also results in a timeout and no
reward. During testing (following completion of stage 13) the ITI
is lengthened to 7 s to produce a slight elevation in impulsive
responding, allowing us to measure either an increase or a
decrease in this behavior. Premature nosepoking is recorded
during training, but data and comparisons reported here are
only during the Testing phase, following completion of stage 13
and achievement of steady state responding. Mice receive either
saline, 0.5 mg/kg CNO, or 2.5 mg/kg CNO i.p. 30 min before
testing. Mice alternate between saline and CNO, again balancing
initial treatment. The chambers were cleaned between each
mouse with Minncare disinfectant to remove residual odors.
In this study, we used a performance threshold of <1.75 s
mean correct response latency, >70% percent accuracy for
inclusion in testing. We did not apply a threshold for omission
errors.
Open Field
For the Open Field assay the lights in the room were turned
down and mice were allowed to acclimate for at least 2 h
prior to testing. The Open Field chamber was constructed
as previously described (Golden et al., 2011). Thirty minutes
after injection of either CNO or saline, mice were placed
into the open field chamber, next to the edge, and allowed
to explore for 5 min while movement was recorded using
EthoVision XT tracking Software (Noldus, Leesburg, VA, USA).
The open field chamber was cleaned between each mouse with
Minncare disinfectant to remove residual odors. During testing,
the lights in the room were turned down, providing a dim light
environment.
Social Interaction
The Social Interaction task was performed in our open field
chamber, as previously described (Golden et al., 2011). Prior
to the social interaction test, all mice were brought to the
behavior room and allowed to acclimate for at least 1 h. Mice
received an injection i.p. of either saline or CNO 30 min
prior to starting the test. In brief, the chamber was prepared
with an empty restrainer in the interaction zone (IZ), against
the wall. A DREADD receptor injected mouse was place in
the chamber, adjacent to the wall opposite the restrainer (as
in the open field assay), and allowed to explore for 150 s.
The DREADD mouse was then removed to the home cage
for 30 s, while the empty restrainer was replaced with a
new, clean restrainer. A novel mouse (129/SJL) was placed in
the new restrainer, and the DREADD mouse was returned
to the chamber and allowed to explore for 150 s. Behavior
and motion were recorded using a video tracking system
and Ethovision Software. The chamber was cleaned between
each mouse with Minncare disinfectant to remove residual
odors.
Immunohistochemistry
Immunohistochemistry of mCitrine for analysis of DREADD
expression was performed following standard procedures, as
previously described (Gaykema et al., 2014). The following
antibody was used for immunodetection: mCitrine (Living
Colors anti-GFP, Clontech, #632592, 1:1000). Briefly, mice
were perfused intracardially and brains were removed and
sectioned on a vibratome. Forty micrometers (40 µm) thick
sections were incubated in PBS containing H2O2 and sodium
azide to suppress endogenous peroxidase activity. Sections were
then incubated in blocking buffer containing 1% normal goat
serum and 0.5% Triton X-100 overnight at 4◦C. Sections
were washed in PBS, and incubated in primary antibody (see
above) overnight at 4◦C. Sections were washed again and
incubated overnight at 4◦C in goat anti-rabbit biotinylated
secondary antibody (1:500), then developed using Ni-DAB
staining and the Vectastain Elite ABC staining kit from
Vector Labs, according to manufacturer’s instructions (Cat.
No. PK-6100, Burlingame, CA, USA). Immunohistochemistry
of SUN2-myc and mCherry for analysis of colocalization
of DREADD and DR1 was performed similarly, with the
following modifications: (1) Sections were initially treated
in NaBH4, diluted to 1 mg/ml in PBS, for 10 min to
reduce autofluorescence, (2) Incubation in H2O2 was omitted,
as was development in Ni-DAB, and (3) The following
antibody combinations were used: for eYFP/SUN2-myc tissue,
rabbit anti-myc (1:1000; Abcam; catalog no. ab9106) plus
Cy3-conjugated goat anti-rabbit antibody (1:1000; Jackson
ImmunoResearch; catalog no. 111–165–144) was used to
visualize AAV-DIO-SUN2-myc infected neurons, while the
epifluoresence of eYFP was used to visualize AAV-CaMKIIa-
EYFP infected neurons. For DREADD/SUN2-myc tissue, rabbit
anti-dsRed (1:5000; Clontech; catalog no. 632496) plus Cy3-
conjugated goat anti-rabbit (1:1000; Jackson ImmunoResearch;
catalog no. 111–165–144) was used to amplify mCherry
fluorescence and thereby visualize AAV-CaMKIIa-hM3D(Gq)-
mCherry infected neurons, followed by Alexa Fluor 488-
conjugated mouse anti-myc (1:1000; Cell Signaling; catalog
no. 9b11) to visualize AAV-DIO-SUN2-myc infected neurons.
Sections were imaged on either an Olympus BX51 microscope
(for Ni-DAB) or a Nikon Eclipse 80i microscope (for
fluorescence).
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 6. In
the Operant and Reinstatement assays, a two-way repeated
measures analysis of variance (rmANOVA) was used to assess
significance. In the Open Field and Social Interaction assays
an unpaired t-test was used. In the Binge-Like and Fast-
Refeed assays, which evaluated consumption at multiple time
points under two conditions, a rmANOVA was used. In
the Impulsivity assay, which measured behavior under several
conditions (Saline, CNO 0.5 mg/kg, and CNO 2.5 mg/kg),
an ANOVA was used to assess effects of treatment, with
a Tukey’s post hoc test used to assess differences between
treatments.
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FIGURE 1 | Expression of hM3Dq designer receptors exclusively activated by designer drugs (DREADD). Anti-mCitrine staining shows expression of the
adeno-associated virus (AAV)-CaMKIIa-HA-hM3D(Gq)-IRES-mCitrine vector reporter in the mPFC (A). Positively stained neurons had a characteristic pyramidal
morphology (B). (C) Single cell RT-PCR of 10 mCherry-positive cells confirmed that DREADD-expressing cells were predominantly glutamatergic (9/10 cells). 8/10
cells also expressed additional tested markers. Lanes 1–10 are picked cells, while lanes 11 and 12 are no-template control reactions. GAPDH, Glyceraldehyde
3-Phosphate Dehydrogenase; VGLUT1, Vesicular Glutamate Transporter 1; VGLU2, Vesicular Glutamate Transporter 2;GAD65a, GAD65b, Glutamic Acid
Decarboxylase 65; GAD67, Glutamic Acid Decarboxylase 67; PARV, Parvalbumin; SOM, Somatostatin; VIP, Vasoactive Intestinal Peptide.
RESULTS
Expression and Activity of hM3Dq
We first confirmed expression and activity of the hM3Dq
DREADD receptor. Immunohistological staining for the
mCitrine reporter co-expressed with the hM3Dq-DREADD
revealed positive staining bilaterally throughout the mPFC
(Figure 1A). Positively stained cells had characteristic pyramidal
neuron morphology (Figure 1B). Staining was observed
predominantly in the prelimbic cortex, but included adjacent
portions of the anterior cingulate and infralimbic cortex as
well. Activity of the CamKIIα promoter is generally regarded
to be restricted to excitatory neurons within the forebrain
(Jones et al., 1994), and this promoter is frequently used
to target AAV vectors to PN within the PFC (for example,
Van den Oever et al., 2013). Nonetheless, we sought to further
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FIGURE 2 | Activity of hM3Dq DREADD. Injection of a depolarizing current step (300 pA) evoked action potential firing in labeled mPFC neuron (n = 10;
6 mice: A). Application of CNO (5 mins) caused membrane depolarization and triggered action potential bursting (n = 19; 6 mice: B). (C) Quantification of the dose
dependent increases in membrane depolarizations and firing rates (D). CNO induced depolarizations and firing bursts were abolished by L-NAME (500 µM; E).
(F) Quantification of reduction in action potential frequency by L-NAME. Values represent means ± SEM. ∗p < 0.001 ANOVA followed by Tukey’s post hoc test.
confirm the phenotype of DREADD-expressing cells by
single cell RT-PCR (scRT-PCR). mCherry positive cells
were predominantly glutamatergic, with 9 of 10 sampled
cells expressing either vesicular glutamate transporter 1
(VGLUT1) or VGLUT2, or both (Figure 1C), confirming
that this vector is highly selective for glutamatergic neurons.
Interestingly, a portion of the cells in this sample also expressed
glutamic acid decarboxylase 65 (GAD65) and GAD67, as
well as parvalbumin (PARV), somatostatin (SOM), and
vasoactive intestinal peptide (VIP; Figure 1C), suggesting a
perhaps unappreciated molecular heterogeneity within the
pyramidal neuron population of the mPFC (see ‘‘Discussion’’
section).
To confirm that application of CNO would evoke neuronal
firing, membrane properties of labeled neurons were recorded
under whole cell current clamp conditions (Figure 2). Injection
of a depolarizing current step evoked firing in labeled
neurons (Figure 2A; n = 10). Bath application of CNO
(3 and 9 µM; n = 19) dose dependently evoked depolarizing
events that triggered a dose dependent increase in bursts
of action potentials (Figures 2B–D). Membrane properties
and frequency of action potentials evoked using either a
depolarizing current injection step or by CNO (9 µM)
application were not different (Figure 2B, Table 1). We then
investigated the mechanism of DREADD driven neuronal
activation, to determine whether it resembled that of the
endogenous M3 muscarinic receptor. Interestingly, similar to
what has been observed followingM3 receptor activation (Fassini
et al., 2015), the effects of CNO (9 µM) were completely
abolished by the nitric oxide (NO) inhibitor L-NAME and
were partially reversible on washout (500 µM; n = 13:
Figures 2E,F). These findings confirm that mPFC PN expressing
DREADD can be activated in a dose dependent manner by
CNO application, and that NO synthesis is required for the
ability of the DREADD receptor to produce an increase in
neuronal activity as has been recently suggested (Fassini et al.,
2015).
Activation of mPFC PN Enhances Operant
Performance for Food Reward
In our initial experiments, we wanted to test whether increasing
mPFC pyramidal neuron activation would enhance conditioned
food seeking; as prior work suggests the mPFC plays an
important role in driving PR responding for reward. AAV
hM3Dq-DREADD-injected mice (N = 16) were first trained
in the absence of CNO stimulation on a FR schedule.
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TABLE 1 | Comparison of hM3D(Gq) activation to 300 pA current injection.
RMP Amplitude Threshold Upstroke Width N
(mV) (mV) velocity (mV/ms) (ms)
300 pA Current injection −60.5 ± 0.1 49.1 ± 0.9 −39.0 ± 0.9 155.4 ± 3.6 2.3 ± 0.1 10
CNO 9 µM −61.1 ± 0.2 48.8 ± 0.7 −38.8 ± 1.0 148.3 ± 4.2 2.3 ± 0.1 19
FIGURE 3 | Excitation of mPFC pyramidal neurons (PN) enhances operant responding. Saline (white bars) had no effect on operant responding in
DREADD-expressing mice (N = 16) relative to wildtype mice (N = 8) in either the food restricted (A) or fed (B) state, whether measured as breakpoint, total
nosepokes delivered, or rewards obtained. In contrast, CNO (striped bars) did enhance operant responding in DREADD-expressing mice relative to wildtype mice in
the food-restricted state, but not in the fed state. Error bars are ±SEM. ∗p < 0.05, 2-way rmANOVA followed by Sidak’s multiple comparisons test.
Upon PR testing, CNO significantly enhanced operant
responding for a highly palatable food reward in food
restricted, DREADD-expressing mice relative to control,
non-DREADD-expressing mice over the first two days of
testing (Figure 3A). Statistical analysis revealed a significant
interaction between DREADD expression and treatment,
whether the data were evaluated as breakpoint (F(1,22),
p = 0.0133), total nosepokes (F(1,22), p = 0.0197), or total
rewards obtained (F(1,22), p = 0.0178). This effect was driven
by a significant difference in responding following CNO
challenge between DREADD-expressing and wildtype mice
(p < 0.05 for Breakpoint, Nosepokes, and Rewards; Sidak’s
multiple comparisons test). Operant responding was not
different between the DREADD-expressing and wildtype
groups on saline, indicating that viral infection and DREADD
expression alone do not impact operant behavior (p > 0.05
for Breakpoint, Nosepokes, and Rewards; Sidak’s multiple
comparisons test). Furthermore, there was no difference in
nosepokes into the inactive ports between the two treatments
at any stage of PR testing (Table 2), demonstrating that the
enhanced nosepoking was specifically directed at obtaining
reward, rather than being a non-specific enhancement of
nosepoking. The enhancing effect of CNO in DREADD-
expressing mice starkly contrasts with results observed in
control mice that did not express DREADD (N = 8). In
contrast to the effects observed in food-restricted mice,
CNO did not enhance operant responding in DREADD-
expressing mice following return to ad lib feeding, as revealed
by the absence of a significant interaction between DREADD
expression and treatment, whether analyzed as breakpoint
(F(1,22), p = 0.8311), total nosepokes (F(1,22), p = 0.7891),
or total rewards obtained (F(1,22), p = 0.7921; Figure 3B).
As in the food-restricted state, CNO in the fed state had
no effect on inactive port entries (Table 3). Taken together,
these results demonstrate that enhancing pyramidal cell
excitability in the mPFC via CNO-DREADD is sufficient to
enhance operant responding in the food-restricted state, but
not under ad-lib fed conditions. Furthermore, our results
in control mice show that CNO alone has no significant
effect on operant behavior in the absence of DREADD, in
contrast to the related compound clozapine (den Boon et al.,
2012).
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TABLE 2 | Nosepokes into inactive ports during progressive ratio (PR)
testing on food restriction.
Saline CNO 0.5 mg/kg
N Pokes σ N Pokes σ
FR5 16 2 1.51 16 2.88 4.94
FR10 16 1.56 1.63 16 2.63 2.78
FR20 16 3.69 4.32 16 5.13 5.02
FR30 16 5.06 4.57 15 6 5.82
FR50 15 11.8 7.41 15 9.6 6.88
FR70 14 14.5 10.1 15 12.33 6.53
FR100 12 23.08 20.5 15 26.87 32.8
FR130 8 17.38 11.7 13 28.46 29
FR170 5 28.6 20 8 34.88 22.3
FR210 2 15.5 20.5 5 22.6 5.32
FR260 2 19 22.6 3 21.67 13.3
FR310 1 13 N/A 1 7 N/A
TABLE 3 | Nosepokes into inactive ports during progressive ratio (PR)
testing on ad lib feeding.
Saline CNO 0.5 mg/kg
N Pokes σ N Pokes σ
FR5 16 3.5 3.2 16 2.5 2.76
FR10 16 1.88 2.42 16 1.31 1.3
FR20 16 2.69 4.33 16 3.25 2.57
FR30 16 4.31 4.81 16 4.56 4.95
FR50 10 11.6 12 13 6.54 4.52
FR70 5 13.8 13.7 8 9.5 7.01
FR100 1 5 N/A 4 12.75 8.46
FR130 0 N/A N/A 1 5 N/A
Activation of mPFC PN Enhances
Reinstatement of Palatable Food Seeking
We next wanted to test whether enhancing pyramidal neuron
activation alters reinstatement responding for food reward.
As prior work has demonstrated that the mPFC acts to
drive reinstatement of drug seeking, we anticipated the same
effect would be seen when animals are tested with palatable
food. All mice (N = 17) successfully passed the reinstatement
acquisition paradigm, with at least 70% of total nosepokes
being made in the center, active hole. Average nose poking
during the final three days of acquisition was significantly
higher than average nose poking during the final three days
of extinction, when no light cue was provided and no reward
delivered (Figure 4; 73.4 ± 4.6 pokes vs. 9.7 ± 0.8 pokes),
indicating the successful extinction of nose poking in the
absence of a cue in all groups of animals. During reinstatement
testing, when the light cue was continuously on for the
duration of the test, mice in both the CNO and saline groups
nose poked significantly more during the test than they did
during the final day of extinction, indicating that the light
cue was sufficient to reinstate food seeking behavior (F(1,15),
p = 0.0004; Figure 4). Importantly, CNO significantly enhanced
nose poking relative to saline during testing, revealed by a
significant interaction between time (Extinction vs. Test) and
group (Group 1/Saline vs. Group 2/CNO; F(1,15), p = 0.0265;
Sidak’s multiple comparisons test, p < 0.01; Figure 4). (CNO:
FIGURE 4 | Exciting mPFC PN enhances reinstatement of food
seeking. Note: Saline or CNO was administered only during the reinstatement
test; the groups are separated during Acquisition and Extinction to
demonstrate nose poking in each group. Mice in both the Saline (N = 8) and
CNO (N = 9) groups successfully reinstated nose poking behavior during the
Reinstatement test. Mice given CNO poked significantly more than mice given
saline during the test. Error bars are ± SEM. ∗p < 0.05, ∗∗∗p < 0.001, 2-way
rmANOVA followed by Sidak’s multiple comparisons test.
30.7 ± 4.7 pokes; Saline: 15.5 ± 2.9 pokes). Our results
demonstrate that enhancing the excitability of mPFC PN via
metabotropic signaling is sufficient to enhance reinstatement of
food seeking behavior.
Activation of mPFC PN Reduces Impulsive
Responding for Food Reward
Motor impulsivity is a behavioral characteristic modified by
prefrontal cortex activity. Consequently, we hypothesized that
similar to the observed effect on PR responding for palatable
food, activation of mPFC PN would lead to a change in attention
and impulsivity as well. We therefore trained DREADD-
expressing mice in the 3-choice serial reaction time task,
which measures a range of parameters including impulsivity,
and then assessed behavior under control and stimulated
conditions (Tsutsui-Kimura et al., 2009). We tested mice
after vehicle saline and CNO at both a low (0.5 mg/kg)
and high (2.5 mg/kg) dose. When we analyzed all mice for
effects of treatment, we found no significant difference in
premature responding (Figure 5A; F(2,31) = 3.027; p = 0.0630),
perseverative responses (F(2,31) = 1.086; p = 0.3500), percent
omissions (F(2,31) = 0.2097; p = 0.8120), or total number of
trials completed (F(2,31) = 0.1973; p = 0.8220). As we observed
a trend toward a reduction in premature responding in all
mice, we reasoned that CNO may have a more dramatic
effect on impulsivity in mice that tend to exhibit more
premature responding in control (saline) conditions; in other
words, highly impulsive mice. Therefore, we also analyzed
for effects of treatment in only those mice with high rates
of premature responding after saline treatment (e.g., those
with premature responses totaling greater than one standard
Frontiers in Behavioral Neuroscience | www.frontiersin.org 9 March 2016 | Volume 10 | Article 63
Warthen et al. mPFC Control of Feeding Behaviors
FIGURE 5 | Exciting mPFC PN reduces impulsivity. CNO did not significantly alter premature responding in DREADD-expressing mice as a group (N = 12) in a
3-choice serial reaction time task when administered at 0.5 mg/kg (striped bars) or 2.5 mg/kg (black bars), relative to saline (white bars) (A). However, in highly
impulsive mice (N = 8) CNO did decrease premature responding (B), an effect attributed to higher doses of CNO (2.5 mg/kg). Error bars are ± SEM. ∗p < 0.05
ANOVA followed by Tukey’s post hoc test.
deviation above the mean of the low-impulsivity group following
saline challenge [>6.5 premature responses, N = 8]). In this
subgroup, we did indeed observe an effect of treatment on
impulsivity (Figure 5B; F(2,19) = 4.122; p = 0.0362), which
was driven by a decrease in premature responses when mice
were treated with a high dose of CNO (p < 0.05). No
significant effect of treatment was observed in this subgroup
on perseverative responses (F(2,19) = 1.450; p = 0.2594),
percent omissions (F(2,19) = 0.2525; p = 0.7794), or total
number of trials completed (F(2,19) = 0.3619; p = 0.7010). We
therefore conclude that enhancing the excitability of mPFC
PN decreases premature responding when required to obtain
a food reward, particularly in mice with a predisposition
toward impulsive responding. Furthermore, this effect is
only apparent at higher doses of CNO that likely produce
a greater degree of neuronal activation. Importantly, in
contrast to the operant and reinstatement assays wherein CNO
increased nosepoking, in the impulsivity assay CNO acted
to decrease nosepoking. This demonstrates that CNO did
not indiscriminately increase nosepoking. Rather, nosepoking
behavior was modified according to the demands of the
task.
While we did not test the effect of CNO in wildtype
animals, the closely related compound clozapine has been
shown to have no effect on premature responding in the
5-choice serial reaction time task, which is the basis of the
3-CSRTT (Baviera et al., 2008). Furthermore, clozapine increases
omission errors in rats in an operant sustained attention
task (Martinez and Sarter, 2008), which we also did not
observe in the 3-CSRTT with CNO. This again supports
the interpretation that the effects we have observed are not
driven by CNO acting upon a pathway normally engaged by
clozapine.
Activation of mPFC PN Does Not Increase
Unconditioned Hedonic or Homeostatic
Food Intake
While prior studies have shown that pharmacological and
optogenetic manipulation of the mPFC can alter free feeding, we
wanted to investigate whether an increase in pyramidal neuron
activation via metabotropic signaling would produce a similar
effect. This approach differs from optogenetic stimulation, where
neurons are stimulated to coordinately fire action potentials
at specific frequencies, and from the application of non-cell
selective receptor agonists and antagonists to the prefrontal
cortex. Interestingly, unlike observations in prior work using
optogenetic and pharmacological methods, we observed no
effect on unconditioned food intake after administration of
CNO, either in the fasted or fed state. In the fed state, CNO
did not significantly alter intake of a highly palatable diet
whether administered at 0.5 mg/kg (Figure 6A) or 2.5 mg/kg
(Figure 6B), relative to saline. In an experiment examining
the effects of a low dose of CNO (0.5 mg/kg), all mice
consumed significant amounts of HFD over time, as revealed
by a significant effect of time on food intake (F(2,36) = 67.35;
p < 0.0001); however, CNO did not modulate intake over
the course of the hour, as shown by the lack of an effect
of treatment (F(1,18) = 0.6698; p = 0.4238). In a separate
experiment examining the effects of a higher dose of CNO
(2.5 mg/kg), all mice again increased total consumption over
the course of the experiment, as revealed by a main effect
of time (F(2,36) = 46.24; p < 0.0001), yet there was no effect
of treatment on consumption (F(1,18) = 0.2828; p = 0.6014).
Likewise, in the fasted state mice ate significantly more
chow over the course of the experiment, as shown by a
significant main effect of time on food intake (F(2,36) = 74.47;
p < 0.0001); however, CNO (2.5 mg/kg) did not alter regular
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FIGURE 6 | Exciting mPFC PN does not alter binge-like consumption.
CNO did not alter consumption of a high fat diet in sated mice (N = 10)
whether administered at 0.5 mg/kg (A) or 2.5 mg/kg (B) when food intake
was measured after 15, 30, and 60 min. Error bars are ± SEM, rmANOVA.
chow intake relative to saline, as demonstrated by the lack
of a significant main effect of treatment on consumption
(Figure 7, (F(2,36) = 0.0016; p = 0.9677). These observations
indicate that the activation of mPFC PN induced by our
treatment is not sufficient to change unconditioned food
intake.
Activation of mPFC PN Does Not Alter
Anxiety-Like Behavior, Social Interaction,
or General Locomotor Activity
Given that the selective activation of mPFC PN produces
effects that are task dependent, we hypothesized that this
selectivity might apply to other behaviors previously shown to
be modulated by mPFC activity. Indeed, CNO administration
had no effect on performance in the open field assay, either
at 0.5 mg/kg or 2.5 mg/kg, relative to saline. Specifically,
there was no significant effect of CNO on time spent in
the center of the arena (Figure 8, 0.5 mg/kg: P = 0.5581;
2.5 mg/kg: P = 0.8707), time spent in the edges of the arena
(Figure 8, 0.5 mg/kg: P = 0.5484; 2.5 mg/kg: P = 0.8192),
or total distance traveled (Figure 8, 0.5 mg/kg: P = 0.7566;
FIGURE 7 | Exciting mPFC PN does not alter food intake after fasting.
Regular chow intake in fasted mice (N = 10) was similar after saline (white
bars) and CNO 2.5 mg/kg (black bars). Error bars are ± SEM, rmANOVA.
2.5 mg/kg: P = 0.3292). Excitation of mPFC PN by CNO-
DREADD therefore does not alter anxiety or locomotor activity.
Furthermore, in a test of social interaction there was no
significant difference in exploration of the novel mouse when
measured as the ratio of time spent near the restrainer
when occupied by novel mouse to time spent near the
restrainer when unoccupied (Figure 9). This was true when
mice were administered either a low CNO dose (0.5 mg/kg;
P = 0.2906) or a high CNO dose (2.5 mg/kg; P = 0.1994).
Our experiments suggest that excitation of mPFC PN by CNO-
mediated stimulation of DREADD is not sufficient, by itself,
to significantly alter exploratory drive in response to a novel
conspecific.
Targeted Neurons Exhibit Partial Overlap
With Drd1-Expressing Population
Unconditioned food intake has previously been shown to be
sensitive to manipulation of dopamine signaling within the
mPFC, particularly through the type 1 dopamine receptor
(Drd1, for further details, see ‘‘Discussion’’ Section). Drd1s
are expressed on PN in the mPFC, but the extent of this
expression is unknown. As we observed no effect of our
stimulation on unconditioned food intake, we sought to evaluate
whether PN targeted by the DREADD AAV also co-express
Drd1s, as a lack of complete overlap could partially explain
the absence of unconditioned feeding effects. As existing
Drd1 antibodies are unreliable, we developed a Cre-dependent
vector in order to be able to label Drd1-expressing neurons
in mice expressing Cre recombinase under control of the
Drd1 promoter (Drd1-Cre mice). This vector, described in
the Methods, encodes a myc-tagged nuclear envelope protein,
SUN (Sad1 and Unc domain) 2, which is only functional
in cells expressing Cre recombinase. Specificity of the vector
was confirmed by a test injection into VGAT-Cre-tdTomato
mice (Vong et al., 2011), which demonstrated that SUN2-
myc expression was restricted to Cre/tdTomato-expressing cells
(Figure 10C). Following this confirmation of vector viability,
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FIGURE 8 | Exciting mPFC PN does not alter behavior in the open field. CNO, whether administered at 0.5 mg/kg (striped bars) or 2.5 mg/kg (black bars) had
no effect on time spent in the center or time spent in the border of an open field arena, relative to saline (white bars). CNO also had no effect on total distance moved
(CNO Panel A,C, N = 7; Saline Panel A,C, N = 7; CNO Panel B,D N = 12, Saline Panel B,D N = 12). Error bars are ± SEM. Unpaired t-test.
FIGURE 9 | Exciting mPFC PN does not alter social interaction. In a social interaction task CNO, whether administered at 0.5 mg/kg (A, striped bar, N = 8) or
2.5 mg/kg (B, black bar, N = 10) had no effect on the ratio of time spent interacting with a novel mouse to time spent interacting with an empty animal restrainer,
relative to saline (white bars, (A) N = 8, (B) N = 12). Error bars are ± SEM. Unpaired t-test.
we coinjected our CamKIIα-driven DREADD AAV, along with
SUN2-myc AAV, into the mPFC of DR1-Cre mice. This allowed
us to determine the co-expression of both hM3D(Gq) and
the Cre dependent nuclear tagged SUN2-myc, which in these
experiments served as a proxy for Drd1 expression. As shown
in Figure 10A, while many cells expressed both DREADD
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and SUN2-myc, many cells also expressed only one antigen,
indicating that the overlap between DREADD-expressing cells
and Drd1-expressing cells is incomplete. These observations
were corroborated by a complimentary experiment, involving
dual injection of an AAV expressing eYFP under control
of the CamKIIα promoter (driving expression in mPFC PN)
and an AAV encoding SUN2-myc AAV, which also showed
incomplete co-expression (Figure 10B). In order to estimate
the extent of overlap, we counted the proportion of DREADD-
expressing cells that also expressed SUN2 in a representative
sample set, and found that approximately 43.2 ± 6.1% of
DREADD-positive cells co-expressed the SUN2-myc marker.
This experiment demonstrates that a vector driven by CamKIIα
and a vector driven by Drd1-dependent expression of Cre
target overlapping, yet distinct neuronal populations within
the mPFC.
DISCUSSION
In our current work we show that increasing the excitability
of mPFC PN via DREADD receptor activation is sufficient
to enhance performance of behaviors aimed at acquiring
highly palatable, rewarding foods. Specifically, we show an
increase in operant responding for a palatable food reward, a
reduction of premature responding to obtain a food reward,
and an increase in reinstatement responding for a highly
palatable food. In stark contrast to the behavioral changes
observed in these contingent, conditioned reward assays, our
PN stimulation paradigm had no effect on food intake under
free feeding conditions. To our knowledge, this marks the
first demonstration of an mPFC manipulation producing
an effect on food-seeking behaviors while simultaneously
sparing effects on unconditioned food intake. Furthermore,
we observed no effect of PN stimulation on behavior in
non-food reward assays: PN stimulation had no effect on
locomotion or anxiety behavior. While social interaction is
considered to be inherently rewarding for rodents, we observed
no effect on behavior in this assay either. These results
are therefore consistent with our manipulation producing
an increase in the valuation of a food reward, absent
effects on free feeding and other measures of behavior.
Indeed, the behavioral alterations we have observed following
hM3Dq activation (operant conditioning, impulsivity, and
reinstatement) all involve relatively high levels of cognitive
demand, requiring decision-making, goal directed behavior,
and attribution of motivational salience. They all also involve
learning and executing a set of behaviors in order to
obtain a reward. In contrast, the assays in which we did
not observe an effect are relatively non-demanding, and do
not require a significant degree of learning or goal/value
updating. Thus, increasing PN activation in the medial
prefrontal cortex through DREADD signaling, above the level
that might be observed during behavioral engagement in
less cognitively demanding tasks such as food consumption
(Caracheo et al., 2013), does not produce any change in
behavioral output. However, during tasks requiring higher
cognitive demand (Caracheo et al., 2013), increasing the gain
of select PN within the frontal cortex has distinct behavioral
consequences. It is worth noting that our treatment improved
behavioral performance in a task-specific manner. That is,
nosepoking was increased in the operant and reinstatement
assay, where nosepoking maximizes reward, whereas nosepoking
was decreased in the impulsivity assay, where refraining from
nosepoking maximizes reward, indicating that PN stimulation
optimized action selection in order to maximize reward
receipt.
Interestingly, these data contrast with recent reports
suggesting that mPFC neurons do indeed regulate non-
contingent food intake. We believe these differences between
our observations and those published previously could have
resulted for several reasons. First, the cell population targeted
in this work, glutamatergic PN, is distinct from those targeted
in previous studies that have shown an effect of mPFC
manipulation on free feeding. For example, stimulation of
µ-opioid receptor-expressing (MOR) neurons in the rat
mPFC via infusion of the MOR agonist DAMGO has been
shown to increase both free feeding and PR responding for
a sucrose reward (Mena et al., 2011; Selleck et al., 2015). In
the cortex, MORs are thought to reside predominantly on
a subclass of GABAergic interneuron expressing vasoactive
intestinal peptide (VIP), a population excluded by our
targeting technique (Taki et al., 2000; Férézou et al., 2007;
Kubota et al., 2011). Interestingly, PN form the final output
pathway of the mPFC, and are therefore downstream of the
MOR interneurons. How MOR signaling alters pyramidal
neuron activity to alter feeding remains to be determined;
however, our stimulation paradigm apparently did not
recapitulate the circuit effects of MOR/VIP interneuron
stimulation, resulting in an absence of free feeding effects.
It is worthwhile noting that stimulation of mPFC MORs
with DAMGO actually increases impulsive action in a
differential reinforcement of low response rates task, in
contrast to our results, which show a decrease in impulsive
action upon PN stimulation (Selleck et al., 2015). The
partial overlap in behavioral effects of MOR stimulation
with pyramidal stimulation, i.e., an increase in operant
responding, could be due to a disinhibitory effect of MOR
stimulation on pyramidal neuron activity, as is suggested
by the circuit structure of mouse visual cortex (Pfeffer
et al., 2013); however, in the mPFC this remains to be
determined.
In addition to opioid-mediated effects on free feeding,
optogenetic stimulation of dopamine type 1 receptor-expressing
(Drd1) neurons in the mPFC has also been shown to increase
free feeding of both grain pellets and a high fat diet, and
stimulation of Drd1 terminals in the amygdala alone is
sufficient to increase free feeding on grain pellets (Land et al.,
2014). At least some Drd1 neurons in the mPFC co-express
MORs (Olianas et al., 2012); whether the two receptors are
co-expressed on amgydala-projecting neurons is unknown. In
any case, our immunohistochemical study shows that while
there is overlap among the populations with active Drd1
and CamKIIα promoters within the mPFC, the majority of
neurons in which the CamKIIα promoter can drive AAV-
Frontiers in Behavioral Neuroscience | www.frontiersin.org 13 March 2016 | Volume 10 | Article 63
Warthen et al. mPFC Control of Feeding Behaviors
FIGURE 10 | Targeted neurons exhibit partial overlap with the DR1 expressing population. (A) Co-injection of AAV-CamKII-hM3D(Gq) and Cre-dependent
SUN2-myc into DR1-Cre mice demonstrated that the neurons targeted in this study only partially overlap with the DR1-expressing population. (A1) SUN2 expression,
demonstrating DR1 promoter activity; (A2) mCherry expression, showing AAV-hM3D(Gq) expression; (A3) Merged image, with example cells of interest identified.
(B) A parallel experiment using AAV-CamKII-eYFP instead of AAV-CamKII-hM3D(Gq) showed similar results. (B1) eYFP epifluoresence; (B2) SUN2 expression;
(B3) Merged image. In (A,B), Filled arrowheads: DR1/SUN2 expression only; Open arrowheads: dual expression of DR1/SUN2 and eYFP/mCherry/DREADD
expression; Arrows: eYFP/mCherry/DREADD expression only. In (C), arrows indicate examples of the expression of both SUN2-myc (C1), tdTomato (C2), and
Merge (C3) in a control experiment, in VGAT-Cre-tdTomato mice (Vong et al., 2011). No Sun2-myc single positive neurons were observed. Scale bars are 100 µm.
mediated expression (of either eYFP or mCherry) do not
co-express a Cre-dependent AAV-delivered payload in Drd1-
Cre transgenic mice. Furthermore, our data confirm a divergence
in the phenotype of CamKIIα-expressing neurons and the
Drd1-expressing population, as not all Drd1-expressing mPFC
neurons express a CamKIIα-driven construct. Taken together,
we conclude that we are neither targeting all Drd1-expressing
neurons in the mPFC, nor does the Drd1-expressing population
consist exclusively of PN, and that this may in part explain
why targeted stimulation of Drd1-expressing mPFC neurons can
enhance free feeding, while targeted stimulation of CamKIIα-
expressingmPFC PNdoes not. As withMORs, the partial overlap
between the neurons targeted in this study with those expressing
Drd1s may explain commonalities between our observations
and those of prior reports. For example, D1R-dependent
activity in the mPFC is required for milnacipran-mediated
suppression of impulsivity (Tsutsui-Kimura et al., 2013). Our
target population includes Drd1-expressing neurons, and so they
likely contribute to the suppression of impulsivity that we have
observed.
An additional explanation for the divergence in our data
from prior reports is the fact that the stimulation technique
used in these experiments is physiologically distinct from
prior optogenetic experiments that have resulted in alterations
in non-contingent feeding. Indeed, our electrophysiological
experiments provide valuable new insight into the mechanisms
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of DREADD signaling while also illustrating the potential role
of endogenous muscarinic receptor activation and NO signaling
in the modulation of behavior. The hM3D(Gq) DREADD
used in this study is derived from the human M3 muscarinic
acetylcholine receptor (Armbruster et al., 2007). As predicted,
we have found that stimulation of hM3D(Gq) in vitro results
in neurophysiological responses similar to those induced by
M3 stimulation. Notably, CNO dose dependently enhances the
generation of action potentials in the prefrontal cortex. As
prior work has shown that M3 muscarinic signaling in the
mPFC involves the generation of NO (Fassini et al., 2015),
we examined whether this mechanism was also important in
driving the neuronal activation by CNO. Indeed, we found
that the increase in action potential generation was ablated
by addition of the NOS inhibitor L-NAME, which further
suggests that CNO stimulation may modulate presynaptic vesicle
release, as well as producing effects on the postsynaptic neuron.
This mechanism of DREADD action likely differs significantly
from that observed with the use of optogenetic approaches, as
channelrhodopsin acts to directly depolarize the target neuron
through an enhancement of sodium and calcium ion influx.
Whether optogenetic stimulation, like DREADD, also engages
retrograde signaling pathways remains an open question. We
speculate that the graded effect of DREADD signaling observed
on action potential generation may underlie our observation that
operant behavioral responding was dependent upon dosage of
the CNO ligand. While a low dose of CNO (0.5 mg/kg) was
sufficient to enhance nosepoking for chocolate flavored food
pellets, a higher dose (2.5 mg/kg) was required to suppress
impulsive responding for a food reward.
Our work also highlights the potential that endogenous
muscarinic signaling in the mPFC may produce similar
effects on food consumption behavior. Muscarinic receptors
are expressed on mPFC PN, and their activation results
in neuronal depolarization and activation of NOS (Fassini
et al., 2015; Kurowski et al., 2015). Our work demonstrates
that driving muscarinic-like receptor activity in the mPFC
can modulate reward seeking behavior in the absence of
effects on attention. These data are in agreement with
the observation that fast nicotinic receptor signaling,
rather than metabotropic muscarinic signaling, likely
carries information regarding attention and arousal in
the mPFC (for review, see Bloem et al., 2014). Further
investigation of the role of muscarinic signaling on food
intake and food rewarded instrumental behavior is therefore
warranted.
Finally, we provide an assessment of the molecular phenotype
of 10 DREADD-expressing cells targeted with an AAV vector
driven by the CamKIIα promoter. Our results demonstrate that
the targeted neurons overwhelmingly display a glutamatergic
phenotype, corroborating previous reports using CamKIIα-
driven vectors to target glutamatergic PN in this brain region
(for example, Van den Oever et al., 2013). Nine out of
ten cells expressed either VGLUT1 or VGLUT2, or both
(Figure 1C). The presence of these transporters is indicative of
an excitatory, glutamatergic phenotype, as VGLUT is required
to load synaptic vesicles with glutamate (Münster-Wandowski
et al., 2016). Interestingly, we also found that some of these
cells expressed mRNA for the markers GAD65, GAD67, PARV,
SOM, and vasoactive intestintal peptide (VIP). Although these
markers are often ascribed to interneuron populations (for
example, Rudy et al., 2011; Xu et al., 2010), our observation
of their coexistence with glutamatergic markers in PN is not
unprecedented. VGLUT1, VGLUT2, GAD65, and GAD67 have
been observed in single cells in a variety of brain regions,
across a range of ages (Danik et al., 2005). In fact, PARV-
Cre mice show Cre functionality in PN in the frontal cortex,
suggesting the presence of PARV in these neurons (Tanahira
et al., 2009). Indeed, a subset of corticostriatal projection
neurons co-express PARV, VGLUT1, and GAD (Jinno and
Kosaka, 2004); this population may account for the PARV-
expressing neurons identified in our sample that also co-
express both GAD and VGLUT (4/5 cells). Several reports
show that PARV, SOM, and VIP are almost always co-
expressed with GABAergic markers in frontal cortex, and are
only infrequently co-expressed with each other, instead seeming
to label distinct populations (Uematsu et al., 2008; Xu et al.,
2010). We found that 4/5 PARV-expressing neurons and 4/4
SOM-expressing neurons also expressed GAD, supporting prior
observations that PARV and SOM frequently co-occur with
GAD. Curiously, we found that 3 of 4 SOM-expressing cells
also co-express PARV, in contrast to reports indicating that
these markers label distinct populations. While unexpected,
this is not unprecedented: a class of neuron expressing
VGLUT1, GAD67, PARV, and SOM has previously been
characterized in the amgydala (Sosulina et al., 2006). The lone
VIP-expressing neuron identified in this study expressed all
other markers tested except VGLUT2. Some mPFC neurons
that project to the nucleus accumbens are known to express
VIP, but whether they also contain PARV and SOM is
unknown (Lee et al., 2014). While 9/10 cells expressed VGLUT,
a single GAD+/PARV+ cell did not (Cell 6). Despite the
apparent lack of a glutamatergic phenotype in this cell, it
may indeed belong to a recently identified population of
VGLUT−/GAD+/PARV+ cells that project from the mPFC to
the nucleus accumbens (Lee et al., 2014). In summary, the
scRT-PCR data indicate that we have predominantly, if not
exclusively, targeted pyramidal projection neurons. Overall, our
observations indicate significant molecular diversity among the
pyramidal cell population of the mPFC. The co-expression of
VGLUT and GAD in mPFC PN is likely important for proper
execution of mPFC function (Münster-Wandowski et al., 2016).
It is possible that the diverse pyramidal subtypes subserve
different components of the behaviors we have assessed. The
phenotypic distinctions among mPFC PN present opportunities
for future intersectional studies of pyramidal neuron subtypes
in controlling feeding behavior and other aspects of PFC
function.
In conclusion, our work demonstrates for the first time that
DREADD-driven neuronal stimulation is sufficient to enhance
both the effort devoted to food seeking and the reinstatement of
cued food seeking behavior, while reducing motor impulsivity.
Surprisingly, no change in affect or food intake was observed,
suggesting that activation of CamKII PN using a Gq coupled
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DREADD drives food seeking behavior but not the ingestion of
food.
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